SHUKRA PHARMACEUTICALS
Back to Balance Sheet
|
SHUKRA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.40 Cr | ₹1.40 Cr | - | ₹1.40 Cr | - |
What is the latest Contingent Liabilities ratio of SHUKRA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.40 Cr |
| Mar2024 | ₹1.40 Cr |
| Mar2023 | - |
| Mar2022 | ₹1.40 Cr |
| Mar2021 | - |
How is Contingent Liabilities of SHUKRA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.40 Cr | 0.00 | |
| Mar2024 | ₹1.40 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹1.40 Cr | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SHUKRA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHUKRA PHARMACEUTICALS | ₹1,940.0 Cr | 5.9% | 39.1% | 134.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
SHUKRA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHUKRA PHARMACEUTICALS | 5.9% |
39.1% |
134.1% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses